Xeroderma pigmentosum G (Q92842): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Xeroderma pigmentoso do grupo de complementação G (XPG) é um subtipo extremamente raro de xeroderma pigmentoso (XP), uma fotodermatose rara que predispõe a cânceres de pele. As manifestações clínicas podem variar, pois alguns pacientes apresentam um fenótipo XP leve (sensibilidade aos raios UV, lesões cutâneas hiper ou hipopigmentadas e aumento da incidência de cânceres de pele) e outros combinam sintomas de XP com manifestações sistêmicas e neurológicas da síndrome de Cockayne (XP/CS complexo). | |||
| description / en | description / en | ||
Xeroderma pigmentosum complementation group G (XPG) is an extremely rare subtype of xeroderma pigmentosum (XP), a rare photodermatosis predisposing to skin cancers. Clinical manifestations can vary as some patients present with a mild XP phenotype (UV sensitivity, hyper- or hypo-pigmented skin lesions and increased incidence of skin cancer) and others combine symptoms of XP with systemic and neurological manifestations of Cockayne syndrome (XP/CS complex). | |||
Revision as of 07:57, 16 August 2026
Xeroderma pigmentosum complementation group G (XPG) is an extremely rare subtype of xeroderma pigmentosum (XP), a rare photodermatosis predisposing to skin cancers. Clinical manifestations can vary as some patients present with a mild XP phenotype (UV sensitivity, hyper- or hypo-pigmented skin lesions and increased incidence of skin cancer) and others combine symptoms of XP with systemic and neurological manifestations of Cockayne syndrome (XP/CS complex).
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_2086751990 |
||
| English | Xeroderma pigmentosum G |
Xeroderma pigmentosum complementation group G (XPG) is an extremely rare subtype of xeroderma pigmentosum (XP), a rare photodermatosis predisposing to skin cancers. Clinical manifestations can vary as some patients present with a mild XP phenotype (UV sensitivity, hyper- or hypo-pigmented skin lesions and increased incidence of skin cancer) and others combine symptoms of XP with systemic and neurological manifestations of Cockayne syndrome (XP/CS complex). |
